Tom R. Norton

Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis.

Tokunbo Yerokun, Janet L. Etheredge, Tom R. Norton et al. · PubMed · 1992 · 41 citations

Pathology, Biosynthesis, Hepatotoxicity +17

2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis.

David P. Ringer, Tom R. Norton, Boyd A. Howell · PubMed · 1990 · 35 citations

Rat Hepatocarcinogenesis, Pathology, Candidate Enzyme +18

Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity

David P. Ringer, Tom R. Norton · Carcinogenesis · 1987 · 24 citations

Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene

David P. Ringer, Tom R. Norton, Bettye Cox et al. · Cancer Letters · 1988 · 15 citations

Dietary Administration, Hepatology, Biochemistry +12

Suppression of natural killer and lymphocyte functions associated with carcinogen-induced premalignant hyperplastic nodules in rat liver.

Richard W. Leu, Tom R. Norton, Mary J. Herriott et al. · PubMed · 1985 · 13 citations

Immunology, Pathology, Immunotherapy +17